Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperkalaemia Prevalence, Recurrence and Treatment in Haemodialysis: A Prospective Multi-centre Cohort Study

NCT04799067 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04799067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04799067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperkalaemia Prevalence, Recurrence and Treatment in Haemodialysis: A Prospective Multi-centre Cohort Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 17, 2021
Completion date
July 18, 2022
Enrollment
600 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis, hyperkalemia, water-electrolyte imbalance